Luisa Hector
Stock Analyst at Berenberg Bank
(3.67)
# 2,136
Out of 4,707 analysts
296
Total ratings
59.4%
Success rate
5.3%
Average return
Main Sectors:
Stocks Rated by Luisa Hector
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: AZN AstraZeneca PLC | Maintained: Buy | 16,000p | 11,876p | +34.73% | 72 | Sep 2, 2026 | |
| EPA: SAN Sanofi | Maintained: Buy | €105.00 | €74.70 | +40.56% | 53 | Aug 24, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $125 → $127 | $148.46 | -14.46% | 35 | Aug 5, 2026 | |
| ABBV AbbVie | Maintained: Buy | $275 | $248.78 | +10.54% | 19 | Aug 5, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 340.00 | CHF 350.50 | -3.00% | 52 | May 8, 2026 | |
| SWX: NOVN Novartis AG | Rated: Hold | CHF 92.00 → CHF 110.00 | CHF 111.80 | -1.61% | 4 | Mar 6, 2026 | |
| LON: BTRW Barratt Redrow plc | Maintained: Hold | 414p | 298p | +38.83% | 1 | Feb 11, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Buy | kr 400.00 → kr 415.00 | kr 292.00 | +42.12% | 7 | Jan 16, 2026 | |
| LON: GSK GSK plc | Maintained: Hold | 1,660p | 1,797p | -7.60% | 7 | Jan 6, 2026 | |
| SNY Sanofi | Maintained: Buy | $63 → $67 | $43.16 | n/a | 11 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $60 | $64.69 | n/a | 18 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €197.00 | €134.60 | n/a | 13 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $43 | $27.79 | n/a | 1 | Jun 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €77.36 | €49.41 | n/a | 1 | Sep 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $14.32 | n/a | 2 | Sep 15, 2016 |
AstraZeneca PLC
Sep 2, 2026
Maintained: Buy
Price Target: 16,000p
Current: 11,876p
Upside: +34.73%
Sanofi
Aug 24, 2026
Maintained: Buy
Price Target: €105.00
Current: €74.70
Upside: +40.56%
Merck & Co.
Aug 5, 2026
Maintained: Hold
Price Target: $125 → $127
Current: $148.46
Upside: -14.46%
AbbVie
Aug 5, 2026
Maintained: Buy
Price Target: $275
Current: $248.78
Upside: +10.54%
Roche Holding AG
May 8, 2026
Maintained: Hold
Price Target: CHF 340.00
Current: CHF 350.50
Upside: -3.00%
Novartis AG
Mar 6, 2026
Rated: Hold
Price Target: CHF 92.00 → CHF 110.00
Current: CHF 111.80
Upside: -1.61%
Barratt Redrow plc
Feb 11, 2026
Maintained: Hold
Price Target: 414p
Current: 298p
Upside: +38.83%
Novo Nordisk A/S
Jan 16, 2026
Maintained: Buy
Price Target: kr 400.00 → kr 415.00
Current: kr 292.00
Upside: +42.12%
GSK plc
Jan 6, 2026
Maintained: Hold
Price Target: 1,660p
Current: 1,797p
Upside: -7.60%
Sanofi
May 16, 2025
Maintained: Buy
Price Target: $63 → $67
Current: $43.16
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: $55 → $60
Current: $64.69
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: €197.00
Current: €134.60
Upside: n/a
Jun 14, 2021
Maintained: Hold
Price Target: $43
Current: $27.79
Upside: n/a
Sep 11, 2018
Maintained: Hold
Price Target: €77.36
Current: €49.41
Upside: n/a
Sep 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $14.32
Upside: n/a